Sandra Orsulic
Affiliations: | Cedars-Sinai Medical Center, Los Angeles, CA, United States |
Google:
"Sandra Orsulic"Children
Sign in to add trainee| Dong-Joo (Ellen) Cheon | post-doc | Albany Medical Center | |
| Dongyu Jia | post-doc | 2015-2017 | Cedars-Sinai Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kasikova L, Rakova J, Hensler M, et al. (2024) Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nature Communications. 15: 2528 |
| Broz MT, Ko EY, Ishaya K, et al. (2024) Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nature Communications. 15: 2498 |
| Hu Y, Recouvreux MS, Haro M, et al. (2024) INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer. Npj Precision Oncology. 8: 35 |
| Saner FAM, Takahashi K, Budden T, et al. (2023) Concurrent RB1 loss and -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma. Medrxiv : the Preprint Server For Health Sciences |
| Zhang Y, Wang Y, Zhao G, et al. (2023) Metabolic dependencies and targets in ovarian cancer. Pharmacology & Therapeutics. 245: 108413 |
| Kang EY, Weir A, Meagher NS, et al. (2022) CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Cancer |
| Richardson MT, Recouvreux MS, Karlan BY, et al. (2022) Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression. Cells. 11 |
| Gertych A, Walts AE, Cheng K, et al. (2022) Dynamic Changes in the Extracellular Matrix in Primary, Metastatic, and Recurrent Ovarian Cancers. Cells. 11 |
| Recouvreux MS, Miao J, Gozo MC, et al. (2022) FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer. Cancers. 14 |
| Meagher NS, Gorringe KL, Wakefield MJ, et al. (2022) Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |